TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
VSee Health ( (VSEE) ) has issued an announcement.
On November 25, 2025, VSee Health, Inc. entered into a securities purchase agreement with an institutional investor to sell approximately 9.8 million shares of common stock and accompanying warrants in a private placement for gross proceeds of about $6 million. The proceeds are intended for working capital and general corporate purposes, with the closing expected around December 1, 2025, subject to customary conditions. The agreement includes provisions for stockholder approval and restrictions on further stock issuance, impacting the company’s financial strategy and shareholder relations.
The most recent analyst rating on (VSEE) stock is a Sell with a $0.50 price target. To see the full list of analyst forecasts on VSee Health stock, see the VSEE Stock Forecast page.
Spark’s Take on VSEE Stock
According to Spark, TipRanks’ AI Analyst, VSEE is a Underperform.
VSee Health’s overall stock score is primarily impacted by its poor financial performance and weak technical indicators. The company’s negative equity and ongoing losses are significant concerns, and the bearish technical signals further weigh on the stock’s outlook. The lack of positive valuation metrics compounds these issues, resulting in a low overall score.
To see Spark’s full report on VSEE stock, click here.
More about VSee Health
VSee Health, Inc. operates in the healthcare industry, focusing on providing telehealth solutions and services.
Average Trading Volume: 13,120,001
Technical Sentiment Signal: Sell
Current Market Cap: $18.99M
Find detailed analytics on VSEE stock on TipRanks’ Stock Analysis page.